Michael Bachmann

Michael Bachmann is a Senior Advisor and a highly accomplished biopharmaceutical executive with over 20 years of experience across the healthcare, biotech, and medical device sectors. He is the founder of Copentown, a boutique healthcare consulting firm that provides strategic solutions to global industry leaders and niche biotech innovators.

Throughout his career, Michael has held senior leadership roles in top-tier pharmaceutical companies. Notably, he was instrumental in overseeing the development of the world’s first GLP-1 analogue, leading the global project team through Phase II and III clinical trials and orchestrating its worldwide launch. His multifaceted background includes expertise in drug development, regulatory submissions, market access, and global strategic governance.

A truly international professional, Michael has held key roles in London, Copenhagen, and Cape Town. He holds an MSc in Economics and Business Administration from Copenhagen Business School. Beyond his professional achievements, Michael is a competitive athlete and a dedicated mentor, bringing a relentless drive for excellence to every strategic initiative he leads at HealthTech180.